We are live on
!
Find out more
PCM
Pentwater Capital Management Portfolio holdings
AUM
$19.3B
1-Year Est. Return
58.13%
This Fund
S&P 500
This Quarter
Est. Return
+28.06%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$8.28B
AUM Growth
+$544M
(+7%)
Cap. Flow
-$651M
Cap. Flow
% of AUM
-7.87%
Top 10 Holdings %
Top 10 Hldgs %
64.5%
Holding
301
New
80
Increased
38
Reduced
62
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WORK
Slack Technologies, Inc.
WORK
|
+$612M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$523M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$380M |
| 4 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$271M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$448M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$333M |
| 3 |
TCO
Taubman Centers Inc.
TCO
|
+$167M |
| 4 |
PG&E
PCG
|
+$160M |
| 5 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$159M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.92% |
| 2 | Healthcare | 7.46% |
| 3 | Materials | 5.96% |
| 4 | Communication Services | 4.33% |
| 5 | Industrials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Williams Companies
WMB
$86.1B
| $3.21M | 0.04% |
160,000
| – | – |
|
|
WTRE
102
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $3.19M | 0.04% |
+92,093
| New | +$3.15M |
|
103
Regeneron Pharmaceuticals
REGN
$80.8B
| $3.14M | 0.04% |
6,500
| – | – |
|
104
Dropbox
DBX
$8.12B
| $3.11M | 0.04% |
140,000
| – | – |
|
105
CALL
Cheesecake Factory
CAKE
$5.33B
| $2.96M | 0.04% |
80,000
-10,000
| -11% | -$343K |
|
|
CHNG
106
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $2.95M | 0.04% |
158,016
| – | – |
|
107
PUT
Tesla
TSLA
$1.3T
| $2.82M | 0.03% |
12,000
-41,400
| -78% | -$7.06M |
|
108
Energy Transfer Partners
ET
$69.3B
| $2.6M | 0.03% |
420,000
-320,000
| -43% | -$1.94M |
|
109
XPeng
XPEV
$11.6B
| $2.58M | 0.03% |
60,249
+44,349
| +279% | +$1.63M |
|
110
Shift4
FOUR
$3.26B
| $2.5M | 0.03% |
33,200
-28,600
| -46% | -$1.71M |
|
111
Vroom Inc
VRM
$48.2M
| $2.5M | 0.03% |
763
+438
| +135% | +$1.45M |
|
112
Academy Sports + Outdoors
ASO
$2.98B
| $2.49M | 0.03% |
+120,000
| New | +$1.94M |
|
|
RNLX
113
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $2.46M | 0.03% |
153,500
-26,000
| -14% | -$321K |
|
114
Zentalis Pharmaceuticals
ZNTL
$302M
| $2.34M | 0.03% |
45,000
-5,000
| -10% | -$226K |
|
115
PUT
Analog Devices
ADI
$190B
| $2.33M | 0.03% |
15,800
| – | – |
|
|
ETNB
116
DELISTED
89bio
ETNB
| $2.27M | 0.03% |
93,000
| – | – |
|
117
Clarivate
CLVT
$1.16B
| $2.23M | 0.03% |
75,000
| – | – |
|
|
BEAT
118
DELISTED
BioTelemetry, Inc.
BEAT
| $2.16M | 0.03% |
+30,000
| New | +$1.57M |
|
119
Elanco Animal Health
ELAN
$11.1B
| $2.14M | 0.03% |
69,775
+15,000
| +27% | +$458K |
|
120
Rackspace Technology
RXT
$1.24B
| $2.1M | 0.03% |
110,000
| – | – |
|
121
Dynatrace
DT
$14.2B
| $2.08M | 0.03% |
48,000
+25,000
| +109% | +$993K |
|
122
BJs Wholesale Club
BJ
$12.3B
| $2.05M | 0.02% |
55,000
+10,000
| +22% | +$400K |
|
|
AZEK
123
DELISTED
The AZEK Co
AZEK
| $2.04M | 0.02% |
53,170
-20,000
| -27% | -$722K |
|
124
Option Care Health
OPCH
$3.56B
| $2.03M | 0.02% |
130,041
+75,041
| +136% | +$1.12M |
|
|
CBMG
125
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $2.02M | 0.02% |
110,000
+34,888
| +46% | +$636K |
|
Similar funds
CS
A
LF
MIM
SPIA
BPA
NAM
Pentwater Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Pentwater Capital Management held 301 positions worth $8.28B, up 7% from $7.73B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Pentwater Capital Management withdrew a net $651M in Q4 2020, closing 67 positions and reducing 62 holdings. Its most notable exit was Immunomedics Inc, an estimated $333M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Materials.
Against the trend, Pentwater Capital Management opened a new position in Slack Technologies, Inc. worth $765M.
- Pentwater Capital Management's largest Q4 2020 buy was Slack Technologies, Inc.: 18,106,000 shares worth $765M.
- Pentwater Capital Management added most to Maxim Integrated Products in Q4 2020, an estimated $150M increase.
- Pentwater Capital Management's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $448M.
- Pentwater Capital Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $333M.
- Pentwater Capital Management's ten largest holdings make up 64% of its $8.28B portfolio in Q4 2020.
- Pentwater Capital Management opened 80 new positions and closed 67 in Q4 2020.
- Pentwater Capital Management's portfolio value rose 7% quarter-over-quarter to $8.28B.
Based on Pentwater Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.